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We report on a young female patient with the clinical features of blepharophimosis-ptosis-
epicanthus inversus syndrome (BPES, OMIM 110100) and a balanced chromosome transloca-
tion 46,XX,t(2;3)(q33;q23)dn.BPES is a rare autosomal dominant congenital disorder charac-
terized by the eponymous oculo-facial features that are, in female patients, associated either
with (type 1 BPES) or without (type 2 BPES) premature ovarian failure. Both types of BPES
are caused by heterozygous mutations in the FOXL2 gene, which is located in chromosome
band 3q23. Chromosome aberrations such as balanced rearrangements have only rarely been
observed in BPES patients but can provide valuable information about regulatory regions of
FOXL2. The translocation in this patient broadens our knowledge of pathogenic mechanisms in
BPES and highlights the importance of conventional cytogenetic investigations in patients with
negative results of FOXL2 mutation screening as a prerequisite for optimal management and
genetic counseling.
Keywords FOXL2; balanced chromosome translocation; blepharophimosis-ptosis-epicanthus in-
versus syndrome; BPES; premature ovarian failure
INTRODUCTION
Blepharophimosis-ptosis-epicanthus inversus syndrome
(BPES, OMIM 110100) is a rare autosomal dominant con-
genital disorder characterized by short palpebral fissures,
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epicanthus inversus, ptosis of the eyelids and additional ocular
and non-ocular features.1 In female patients, BPES can be
associated with premature ovarian failure (POF), menstrual
irregularities or infertility (type 1 BPES); or it is not associated
with fertility problems (type 2 BPES).2,3
In the majority of patients, BPES is caused by heterozygous
mutations of the FOXL2 gene which encodes a forkhead tran-
scription factor that is expressed in the developing eyelid and
ovaries4,5 BPES is rarely associated with chromosome aberra-
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recessive form of BPES associated with a homozygous FOXL2
mutation has recently been reported in a consanguineous Indian
family.8
Here, we report a young BPES patient in whom FOXL2
mutation analysis failed to identify a mutation, but subsequent
chromosome analysis revealed a de novo balanced chromosome
translocation involving the FOXL2 locus.
CLINICAL REPORT
The patient was born to healthy and non-consanguineous par-
ents after an uneventful pregnancy in the 37th gestational week.
Birth parameters were within the normal range [length 47 cm
(50th centile); weight 3365 g (50th centile); head circumference
32 cm (10th centile)]. Psychomotor development was normal.
On examination at the age of 14 months, her height was
75 cm (25th centile) and head circumference 46 cm (25–50th
centile). Facial dysmorphic features included short palpebral
fissures (blepharophimosis) and lateral displacement of inner
canthi (telecanthus), bilateral ptosis of eyelids, bilateral epican-
thus inversus, sparse eyebrows, long philtrum, flat nasal bridge
and anteverted nares (Figure 1A). Ophthalmologic investiga-
tions revealed no abnormalities of the eye or the retina. The




For FOXL2 mutation analysis we used the primers as reported
in Crisponi et al. (2001).4 Details of the PCR and sequencing
conditions are available upon request.
Karyotyping, Array CGH and FISH
Cytogenetic investigations (GTG banding) on 25 metaphases
obtained from PHA-stimulated peripheral lymphocytes were
performed according to standard protocols.
Array comparative genomic hybridisation (array CGH)
analysis was performed on a “32k” BAC array as de-
scribed previously.9 Aberrations were only considered if at
least three adjacent clones were involved unless they coin-
cided with published DNA copy number variants as listed
in the Database of Genomic Variants (http://projects.tcag.ca/
variation/). Detailed step-by-step protocols are provided on
our website (http://www.molgen.mpg.de/∼abt rop/ molecular
cytogenetics/).
For fluorescence in situ hybridization (FISH) experiments,
a permanent lymphoblastoid cell line of the patient was es-
tablished by EBV transformation according to standard proto-
cols after informed consent. FISH was performed using three
BAC clones (RP11-186B11; RP11-809A16; RP11-34M23) at
and around the FOXL2 locus in 3q32. The BAC clones
were selected from the Human “32k” BAC Re-Array set
(http://bacpac.chori.org/pHumanMinSet.htm; kindly provided
FIG. 1A. (A) The patient at age 14 months. Note short palpe-
bral fissures, low nasal bridge, ptosis and epicanthus inversus.
(B) Hybridization signals (red) of the breakpoint-spanning BAC
RP11-809A16 on the normal chromosome 3, derivative chromo-
some 2 [der(2)], and derivative chromosome 3 [der(3)]. (C) Par-
tial karyogram showing G-banded homologues and ideograms
of the normal chromosomes 2 (yellow) and 3 (red), and of the
translocation chromosomes. The breakpoints are in chromosome
bands 2q33 and 3q23 (arrows).
by Pieter de Jong, Children’s Hospital Oakland Research Insti-
tute). DNA samples were prepared according to standard proto-
cols and were labelled by nick translation with either biotin-16-
dUTP or digoxigenin-11-dUTP. Immunocytochemical detection
of probes was performed as described elsewhere.10 Chromo-
somes were counterstained with 46-diamino-2-phenyl-indole
(DAPI). Metaphases were analysed with a Zeiss epifluorescence
microscope.
RESULTS
No Mutation in FOXL2
Sequencing of FOXL2 failed to detect pathogenic mutations.
A Chromosome Breakpoint Affects the FOXL2 Locus
Chromosome analysis in the patient revealed a balanced re-
ciprocal translocation between one homologue of chromosome
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(Figure 1C). The chromosomes of the parents were nor-
mal. The patient’s karyotype was determined as 46,XX,t(2;3)
(q33;q23)dn. Analysis by whole genome array CGH confirmed
the balanced character of the translocation and revealed no copy
number changes elsewhere in the genome that were no known
polymorphisms.
Molecular cytogenetic analysis using FISH revealed a
breakpoint-spanning BAC clone (RP11-809A16) with split sig-
nals on both derivative chromosomes, and one signal on the unaf-
fected chromosome 3 (Figure 1B). The neighboring BAC clones
yielded signals proximal to the breakpoint (RP11-186B11) and
distal to the breakpoint (RP11-34M23) (data not shown).
The breakpoint-spanning BAC RP11-809A16 has a size of
about 170 kb and harbors the FOXL2 gene. Thus, the precise
position of the breakpoint is either within FOXL2 or, given the
small genomic size of 2.7 kb of this single-exon gene, upstream
or downstream of FOXL2.
DISCUSSION
Most BPES patients have mutations within FOXL2, and
the FOXL2 mutation database lists more than 100 pathogenic
alleles.5 In contrast, genomic aberrations such as microdeletions
or chromosome rearrangements involving the FOXL2 locus are
rare,6,7 and very few balanced chromosome translocations have
been reported to be associated with BPES.11−13
The unambiguous clinical features of our patient led us to
analyze FOXL2, which, however, failed to identify a causative
mutation. Subsequent chromosome analysis revealed a de novo
balanced translocation t(2;3)(q33;q23), and by molecular cy-
togenetic analysis we could show that the breakpoint in 3q23
affects FOXL2 either by direct disruption or a position effect.
Position effects on the expression of FOXL2 by translocation
breakpoints or extragenic deletions more than 200 kb upstream
of the transcription start site have been reported recently.7,11
Similar position effects spanning up to 1 Mb have also been
observed in other disorders and provide valuable information
about long-range cis-acting regulatory elements of the respec-
tive genes.14
The presence of a chromosome rearrangement in a pa-
tient with a monogenic disorder illustrates the importance of
conventional cytogenetic analyses in situations where molec-
ular genetic tests of the respective genes are available, but
re-sequencing of these genes fails to identify causative muta-
tions. In BPES patients, molecular and/or cytogenetic confir-
mation of the clinical diagnosis is important not only to ex-
clude other disorders associated with blepharophimosis [e.g.
Michels syndrome (OMIM 257920), Ohdo syndrome (OMIM
249620), Marden-Walker syndrome (OMIM 248700), Dubowitz
syndrome (OMIM 223370) or the syndrome reported by Khan
et al.,15 but also because female patients can be at risk to develop
premature ovarian failure or other fertility problems (BPES
type 1). Firm establishment of the diagnosis in childhood pro-
vides the rationale for pre-symptomatic tests of ovarian func-
tion, early therapeutic intervention (e.g. hormone replacement
therapy, ovarian tissue cryopreservation) and/or counseling for
reproductive choices (e.g. to plan pregnancies earlier rather than
later in life).16−20 Knowledge of a balanced chromosome rear-
rangement is even more important for those patients who are
able to procreate, since the formation of germ cells with un-
balanced chromosome complements can lead to reduced fer-
tility rates, higher risks for abortions and increased risks for
the birth of disabled children with unbalanced chromosome
aberrations.
In summary, the unusual chromosome disorder of this patient
adds to our understanding of the pathogenesis of BPES and high-
lights the importance of conventional cytogenetic investigations
in patients with negative results in FOXL2 mutation screening as
a prerequisite for optimal management and genetic counseling.
ACKNOWLEDGMENTS
We thank the parents of the patient for their support and
Hannelore Madle and Susanne Freier for technical assistance.
We gratefully acknowledge support from the German Na-
tional Genome Research Network (NGFN, project numbers
01GR0105 and 01GR0414).
REFERENCES
1. Oley C, Baraitser M. Blepharophimosis, ptosis, epicanthus inversus
syndrome (BPES syndrome). J Med Genet. 1988;25:47–51.
2. Zlotogora J, Sagi M, Cohen T. The blepharophimosis, ptosis, and
epicanthus inversus syndrome: delineation of two types. Am J Hum
Genet. 1983;35:1020–1027.
3. Fraser IS, Shearman RP, Smith A, et al. An association among
blepharophimosis, resistant ovary syndrome, and true premature
menopause. Fertil Steril. 1988;50:747–751.
4. Crisponi L, Deiana M, Loi A, et al. The putative fork-
head transcription factor FOXL2 is mutated in blepharophimo-
sis/ptosis/epicanthus inversus syndrome. Nat Genet. 2001;27:159–
166.
5. Beysen D, Vandesompele J, Messiaen L, et al. The human FOXL2
mutation database. Hum Mutat. 2004;24:189–193.
6. de Ru MH, Gille JJ, Nieuwint AW, et al. Interstitial deletion in
3q in a patient with blepharophimosis-ptosis-epicanthus inversus
syndrome (BPES) and microcephaly, mild mental retardation and
growth delay: clinical report and review of the literature. Am J Med
Genet A. 2005;137:81–87.
7. Beysen D, Raes J, Leroy BP, et al. Deletions involving long-
range conserved nongenic sequences upstream and downstream
of FOXL2 as a novel disease-causing mechanism in blepharophi-
mosis syndrome. Am J Hum Genet. 2005;77:205–218.
8. Nallathambi J, Moumne L, De Baere E, et al. A novel polyalanine
expansion in FOXL2: The first evidence for a recessive form of
the blepharophimosis syndrome (BPES) associated with ovarian
dysfunction. Hum Genet. 2007;121:107–112.
9. Erdogan F, Chen W, Kirchhoff M, et al. Impact of low copy repeats
on the generation of balanced and unbalanced chromosomal aber-
rations in mental retardation. Cytogenet Genome Res. 2006:115.
10. Wirth J, Nothwang HG, van der Maarel S, et al. Systematic charac-
terisation of disease associated balanced chromosome rearrange-














































40 A. TZSCHACH ET AL.
identify microdeletions and candidate regions for mental retarda-
tion genes. J Med Genet. 1999;36:271–278.
11. Crisponi L, Uda M, Deiana M, et al. FOXL2 inactivation by a
translocation 171 kb away: analysis of 500 kb of chromosome
3 for candidate long-range regulatory sequences. Genomics.
2004;83:757–764.
12. Praphanphoj V, Goodman BK, Thomas GH, et al. Molecular cyto-
genetic evaluation in a patient with a translocation (3;21) associ-
ated with blepharophimosis, ptosis, epicanthus inversus syndrome
(BPES). Genomics. 2000;65:67–69.
13. De Baere E, Fukushima Y, Small K, et al. Identification of
BPESC1, a novel gene disrupted by a balanced chromosomal
translocation, t(3;4)(q23;p15.2), in a patient with BPES. Genomics.
2000;68:296–304.
14. Velagaleti GV, Bien-Willner GA, Northup JK, et al. Position ef-
fects due to chromosome breakpoints that map approximately 900
Kb upstream and approximately 1.3 Mb downstream of SOX9
in two patients with campomelic dysplasia. Am J Hum Genet.
2005;76:652–662.
15. Khan AO, Alam SK, Aldahmesh M, et al. Familial
blepharophimosis-like syndrome with esotropia, uveal coloboma,
and short stature. Ophthalmic Genet. 2006;27:79–82.
16. Goswami D, Conway GS Premature ovarian failure. Hum Reprod
Update. 2005;11:391–410.
17. Fassnacht W, Mempel A, Strowitzki T, et al. Premature ovarian
failure (POF) syndrome: towards the molecular clinical analysis of
its genetic complexity. Curr Med Chem. 2006;13:1397–1410.
18. De Baere E, Copelli S, Caburet S, et al. Premature ovarian fail-
ure and forkhead transcription factor FOXL2: blepharophimosis-
ptosis-epicanthus inversus syndrome and ovarian dysfunction. Pe-
diatr Endocrinol Rev. 2005;2:653–660.
19. Fokstuen S, Antonarakis SE, Blouin JL .FOXL2-mutations in
blepharophimosis-ptosis-epicanthus inversus syndrome (BPES):
challenges for genetic counseling in female patients. Am J Med
Genet A. 2003;117:143–146.
20. Donnez J, Dolmans MM, Demylle D, et al. Livebirth after or-
thotopic transplantation of cryopreserved ovarian tissue. Lancet.
2004;364:1405–1410.
D
o
w
n
lo
ad
ed
 B
y:
 [
Ma
x 
Pl
an
ck
 I
ns
t 
& 
Re
se
ar
ch
 G
ro
up
s 
Co
ns
or
ti
um
] 
At
: 
14
:0
9 
11
 M
ar
ch
 2
00
9
